Open Nav

NovoClade

  • Siba Das, NovoClade

Biotechnology company focused on genome editing and developing technologies to control mosquito populations. The process includes genetically editing mosquito eggs in an effort to eliminate disease-carrying insects and create a sterile population. This technique of culling the diseased population of mosquitoes eliminates the need for toxic chemicals that can have detrimental effects on surrounding wildlife.

  • Date:Tuesday, July 9
  • Time:1:30 PM - 1:45 PM
  • Room:Booth 400
  • Location:Booth 400, Exhibition Hall
  • Session Type:Start-Up Stadium
Speakers
Siba Das
NovoClade
Back